IP Library Granted Patent US 7,354,593
Granted Patent B2
US 7,354,593 · App. 11/348,084 · Granted Apr 8, 2008

Coccidial vaccine and methods of making and using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,354,593
App. No.
11/348,084
Granted
Apr 8, 2008
Kind
B2
Abstract

The present invention relates to a vaccine for coccidiosis in chickens prepared from three attenuated Eimeria species: E. acervulina, E. maxima and E. tenella . The vaccine was similar to or superior to other anticoccidial drugs in stimulating protective immunity against coccidiosis.

Claims (19)

1. An immunogenic or vaccine composition for protection against E. acervulina, E. maxima and E. tenella consisting of a pharmaceutically acceptable excipient and a mixture of sporulated oocysts isolated from precocious strains of E. acervulina, E. maxima and E. tenella , wherein the mixture is about 500 oocysts of E. acervulina , about 50 to about 100 oocysts of E. maxima and about 100 to about 250 oocysts of E. tenella.

2. The composition of claim 1 wherein the mixture is about 500 oocysts of E. acervulina , about 100 oocysts of E. maxima and about 100 oocysts of E. tenella.

3. The composition of claim 1 wherein the mixture is about 500 oocysts of E. acervulina , about 50 oocysts of E. maxima and about 250 oocysts of E. tenella.

4. An immunogenic or vaccine composition for protection against E. acervulina, E. maxima and E. tenella consisting of a pharmaceutically acceptable excipient and a mixture of sporulated oocysts, wherein the mixture of sporulated oocytes consists of sporulated oocysts isolated from precocious strains of E. acervulina, E. maxima and E. tenella , wherein for every 10 sporocysts of E. acervulina , there are about 1 to 2 sporocysts of E. maxima and about 2 to 10 sporocysts of E. tenella.

5. The composition of claim 4 wherein for every 10 sporocysts of E. acervulina , there are about 2 sporocysts of E. maxima and about 2 sporocysts of E. tenella .

6. A method of eliciting an immune response comprising administering an effective amount of the immunogenic or vaccine composition of claim 1 to induce the response in a chicken.

7. A method for inducing an immunological or protective response comprising administering an effective amount of the immunogenic or vaccine composition of claim 1 to induce the response in a chicken.

8. A method of eliciting an immune response comprising administering an effective amount of the immunogenic or vaccine composition of claim 4 to induce the response in a chicken.

9. A method for inducing an immunological or protective response comprising administering an effective amount of the immunogenic or vaccine composition of claim 4 to induce the response in a chicken.

10. The method of claim 6 wherein the effective amount is about 500 oocysts of E. acervulina , about 50 to about 100 oocysts of E. maxima and about 100 to about 250 oocysts of E. tenella.

11. The method of claim 7 wherein the effective amount is about 500 oocysts of E. acervulina , about 50 to about 100 oocysts of E. maxima and about 100 to about 250 oocysts of E. tenella.

12. The method of claim 6 wherein the effective amount is about 500 oocysts of E. acervulina , about 100 oocysts of E. maxima and about 100 oocysts of E. tenella.

13. The method of claim 7 wherein the effective amount is about 500 oocysts of E. acervulina , about 100 oocysts of E. maxima and about 100 oocysts of E. tenella.

14. The method of claim 8 wherein the effective amount of the mixture of sporulated oocysts, wherein for every 10 sporocysts of E. acervulina , there are about 2 sporocysts of E. maxima and about 2 sporocysts of E. tenella in the mixture.

15. The method of claim 9 wherein the effective amount of the mixture of sporulated oocysts, wherein for every 10 sporocysts of E. acervulina , there are about 2 sporocysts of E. maxima and about 2 sporocysts of E. tenella in the mixture.

16. The method of claim 6 wherein the effective amount is sufficient to resist a challenge dose of about 100,000 to about 500,000 oocysts of E. acervulina and about 10,000 to about 1,000,000 oocysts of E. maxima or about 10,000 to about 100,000 oocysts of E. tenella to the animal.

17. The method of claim 7 wherein the effective amount is sufficient to resist a challenge dose of about 100,000 to about 500,000 oocysts of E. acervulina and about 10,000 to about 100,000 oocysts of E. maxima or about 10,000 to about 100,000 oocysts of E. tenella to the animal.

18. The method of claim 8 wherein the effective amount is sufficient to resist a challenge dose of about 100,000 to about 500,000 oocysts of E. acervulina and about 10,000 to about 1,000,000 oocysts of E. maxima or about 10,000 to about 100,000 oocysts of E. tenella to the animal.

19. The method of claim 9 wherein the effective amount is sufficient to resist a challenge dose of about 100,000 to about 500,000 oocysts of E. acervulina and about 10,000 to about 1,000,000 oocysts of E. maxima or about 10,000 to about 100,000 oocysts of E. tenella to the animal.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2016
From: MERIAL LIMITED
To: MERIAL, INC.
Reel/Frame 038995/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2006
From: MCDOUGALD, LARRY; FULLER, ALBERTA LORRAINE
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 018468/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2006
From: PRITCHARD, JOYCE ANITA
To: MERIAL LIMITED
Reel/Frame 018468/0614 →